Nigeria · NAFDAC · Regulatory guide
NAFDAC Drug Registration: Nigeria’s Approval Process for Imported Medicines
What NAFDAC actually asks for, in the order it asks for it: the NAPAMS steps, the documents and who supplies each one, the risk category that decides how deep the review goes, the 240-working-day clock, and the fees.
The short answer
To register an imported medicine in Nigeria, a company incorporated in Nigeria applies to NAFDAC on its NAPAMS portal, one application per product. The 2025 guideline sets five steps:[1]
- Dossier screening and document upload
- A permit to import registration samples, plus label vetting
- Laboratory analysis of the samples
- Approval by the Food and Drug Registration Committee (FDRC), after dossier review, GMP inspection of the factory and lab results
- An electronic Certificate of Registration, valid for five years
NAFDAC’s official clock is 240 working days from acceptance to registration number, and it stops whenever NAFDAC is waiting for your answers.[1]
Updated October 2026. Rebuilt against NAFDAC’s March 2025 imported-drug guideline. It sets a 240-working-day clock, replacing the 120 working days in the 2018 edition that many guides still quote. This edition also adds the 2024 risk-categorisation rules and the 2025 reliance route.
Nigeria’s drug registration and approval process at a glance
NAFDAC’s Drug Registration and Regulatory Affairs (DR&R) Directorate runs product registration. The rules for medicines made outside Nigeria are in Guidelines for Registration of Imported Drug Products in Nigeria (DR&R-GDL-005-03), effective 20 March 2025 and due for review in 2030.[1] Applications, payments, query responses and certificates all run through NAPAMS, the NAFDAC Automated Product Administration and Monitoring System.[2]
NAFDAC is one of the African regulators the World Health Organization lists at Maturity Level 3.[3] In practice, that means a documented process run to published guidelines, so expect a full, formal review rather than a paperwork formality.
Who can apply for NAFDAC registration of an imported medicine
The applicant must be a business incorporated with Nigeria’s Corporate Affairs Commission (CAC). A foreign manufacturer cannot hold the application on its own.[1] What ties the Nigerian applicant to the overseas factory depends on who owns the brand:
- The manufacturer owns the brand. The applicant files a Power of Attorney from the manufacturer. It must be signed by a senior company officer, state brand ownership, run for at least five years, and be notarised in the country of manufacture.
- The Nigerian company owns the brand. It files a Contract Manufacturing Agreement with the factory instead, also notarised in the country of manufacture.
The trademark must be registered in Class 5 with Nigeria’s Trademark Registry, in the brand owner’s name.[1] That is not a formality: the brand owner and the registration holder are the parties who control the product in Nigeria afterwards.
The NAFDAC registration process on NAPAMS, step by step
Before step 1, the applicant registers as a client on NAPAMS (registration.nafdac.gov.ng). The same account is used later to answer compliance directives, pay invoices, request variations and renew.[2] Each product needs its own application form.[1]
-
Dossier screening and document upload
Importer files · manufacturer supplies the dossier
Human drug applications need dossier screening clearance first. The dossier is in Common Technical Document (CTD) format, and generics must include a bioequivalence report or biowaiver data.[1] NAFDAC’s Dossier Submission Guide sets quarterly upload windows (the first two weeks of each quarter), with a limit of two products per applicant per window. Zipped or non-CTD uploads are rejected.[4]
-
Permit to import samples, and label vetting
NAFDAC issues · importer receives
Once the documents pass review, NAFDAC issues a permit to import registration samples, and the labels are vetted.[1] Labels must carry the generic name directly under the brand name, plus the NAFDAC number, batch number, manufacturing and expiry dates, and storage conditions, with an English translation of any foreign-language text. A label that closely resembles an already-registered product is not eligible.
-
Laboratory sample submission
Importer submits · manufacturer provides samples and CoA
The importer submits the samples with a cover letter, proof of fee payment, a copy of the sample import permit, and a Certificate of Analysis on the QC laboratory’s letterhead. The CoA must show the brand name, batch number, manufacturing and expiry dates, and the analyst’s name, designation and signature.[1]
-
In parallel: GMP inspection of the factory
Manufacturer hosts · NAFDAC inspects
The manufacturer’s letter of invitation for GMP inspection must give the factory address, not the head-office address, and contact details for the manufacturer and the local agent.[1] In NAFDAC’s published tariff, a foreign pharmaceutical site inspection costs US$10,989.01 per site, and an inspection stays valid for three years.[5]
-
Approval by the Food and Drug Registration Committee
NAFDAC decides
The FDRC considers the product once the dossier review, the GMP inspection and (where applicable) the laboratory analysis are satisfactory.[1]
-
Electronic Certificate of Registration
NAFDAC issues · importer holds
The certificate and NAFDAC number are valid for five years. Registration does not include advertising approval, which needs a separate application.[1]
Which review will your product get? NAFDAC’s risk categories
Since December 2024, NAFDAC sorts every human-drug dossier into low, medium or high risk, and the category sets how deep the review goes.[6]
- Low risk: lighter checks.
- Medium risk: screening, then an abridged review.
- High risk: screening against a comprehensive checklist, then a full dossier review.
Products approved by a stringent regulatory authority (SRA) or prequalified by WHO may qualify for the 2025 reliance procedure. Under it, NAFDAC aims to decide within 60 working days.[7]
Answer the four questions above. The result follows NAFDAC’s 2024 risk-categorisation guideline. NAFDAC assigns the final category itself.
NAFDAC registration documents, and who supplies each one
This is the list in the 2025 guideline, plus the items requested at sample stage.[1] The “usually supplied by” column is our practical split between the Nigerian importer and the overseas manufacturer, not NAFDAC wording.
| # | Document | Usually supplied by | What NAFDAC specifies |
|---|---|---|---|
| 01 | Dossier screening clearance | Importer | Prerequisite for human drug applications |
| 02 | Application letter to the Director-General | Importer | On company letterhead |
| 03 | Notarised declaration (Appendix I) | Importer | Signed by the declarant, notarised in Nigeria |
| 04 | Power of Attorney, or Contract Manufacturing Agreement | Manufacturer | Notarised in the country of manufacture. The PoA states brand ownership and runs at least five years |
| 05 | CAC certificate of incorporation | Importer | Nigerian incorporation evidence |
| 06 | Manufacturing licence or Certificate of Free Sale | Manufacturer | Issued by the regulator in the country of manufacture |
| 07 | Certificate of Pharmaceutical Product (CoPP) | Manufacturer | WHO format, authenticated by the Nigerian Embassy or High Commission (or a Commonwealth/ECOWAS mission where Nigeria has none) |
| 08 | Current GMP certificate | Manufacturer | Valid at submission, authenticated the same way as the CoPP |
| 09 | Trademark registration (Class 5) | Brand owner | Nigerian Trademark Registry, in the owner’s name |
| 10 | Superintendent Pharmacist annual licence | Importer | Issued by the Pharmacists Council of Nigeria |
| 11 | Premises retention licence | Importer | Valid for the importer’s facility |
| 12 | Letter of invitation for GMP inspection | Manufacturer | Factory address (not head office), contacts for manufacturer and local agent, product names |
| 13 | CTD dossier | Manufacturer | Generics: bioequivalence report or biowaiver data |
| 14 | Certificate of Analysis | Manufacturer | QC lab letterhead; batch, dates, analyst’s name, designation, signature |
| 15 | Label and artwork | Manufacturer, approved by importer | Generic name under brand name, NAFDAC number, batch, dates, storage, English text |
Scroll the table sideways to see every column.
Items 07 and 08 are where Indian dossiers lose the most calendar time. Both certificates must be authenticated by the Nigerian mission, so book that step before the dossier goes in, not after the first query. For the wider export document set, see the pharmaceutical export documentation checklist.
How long NAFDAC drug registration really takes
Most of the confusion online comes from guides quoting a superseded edition. Here is every figure with its source and what it actually counts.
| Measure | Figure | What it counts | Source |
|---|---|---|---|
| Official clock, current guideline | 240 working days | Acceptance to registration number. Stops while NAFDAC waits on you | [1] |
| Official clock, 2018 edition (superseded) | 120 working days | The same clock. Replaced on 20 March 2025 | [8] |
| Your time to answer a query | 90 working days | After that, the application closes automatically | [1] |
| Reliance procedure | 60 working days | Roughly 90 calendar days. SRA-approved or WHO-PQ products only | [7] |
| Measured mean, generics, full review (2023) | 247 calendar days | Actual approvals in an ECOWAS-MRH study of seven regulators | [9] |
| NAFDAC service charter | 90 days | A general pledge across all regulated products, not drug-specific | [10] |
Scroll the table sideways to see every column.
A planning number you can defend
At five working days a week, 240 working days is about 48 weeks, or roughly 11 months, before any clock-stop or public holiday is added. That is our arithmetic, not a NAFDAC figure. The measured 2023 mean for generics under full review was shorter, at 247 calendar days.[9] The same study gives NAFDAC’s target as 240 days excluding applicant time, while the guideline says 240 working days. Treat the guideline as binding.
Three things push you past the average: a high-risk category, a GMP inspection still waiting to be scheduled, and slow answers to queries. The first and third are under your control.
NAFDAC registration fees for imported medicines
These figures come from the tariff NAFDAC links on its tariff page, effective 31 January 2020. Imported products are charged in US dollars, per product.[5] NAFDAC can revise its tariff, so confirm the current figures with NAFDAC before you budget.
| Tariff line | Foreign (USD) | Note |
|---|---|---|
| Over-the-counter medicine (OTC) | $967.00 | Per product |
| Prescription-only medicine, POM 1 | $1,280.00 | Medicines that can be manufactured in Nigeria |
| Prescription-only medicine, POM 2 | $1,200.00 | No existing manufacturing facility in Nigeria |
| GMP inspection, foreign pharmaceutical site | $10,989.01 | Per site. Inspection valid three years |
| Renewal | 80% of new fee | Every five years |
Scroll the table sideways to see every column.
Note the design of the tariff: a prescription medicine Nigeria can already make (POM 1) costs more to register from abroad than one it cannot (POM 2). The single biggest line is the factory inspection, and it is charged per site, not per product. Five products from one inspected site share one inspection fee.
Indicative only, not a quotation. This covers NAFDAC tariff lines only. It excludes notarisation, embassy authentication, trademark filing, sample freight, CRIA pre-shipment testing, consultant fees and any naira-denominated charges.
For how these figures compare with Ghana, Kenya, Uganda, Tanzania, Rwanda, Ethiopia and Zambia, see our eight-country drug registration fee comparison.
After registration: shipping, verification and renewal
A NAFDAC number does not clear a shipment
Consignments of regulated products from India and China need a Clean Report of Inspection and Analysis (CRIA) from a NAFDAC-accredited agent before they ship. NAFDAC’s list, current as of 15 April 2025, named five agents for India.[11] What those agents check and how long it takes is covered in NAFDAC CRIA agents in India. The full sequence (PCN premises, NAFDAC registration, Form M, CRIA and port release) is in how to import medicines from India to Nigeria.
Check a registration on the Greenbook
NAFDAC’s Greenbook is Nigeria’s public register of approved products. It can be searched by product name, active ingredient, NAFDAC registration number or applicant.[12] Importers can also use it before they commit: search the molecule to see how many registered generics already compete for the same prescription.
Renewal every five years
The renewal guideline asks for the application at least six months before the certificate expires, filed through NAPAMS.[13] It needs a current CoPP, a Product Quality Review and Quality Information Summary, a list of approved variations and, if the old one has lapsed, a new Power of Attorney. The renewal clock is 90 working days, and an unanswered query closes the renewal after 45 working days. Renewal costs 80% of the new-registration fee.[5]
Where NAFDAC applications stall, and how to avoid it
- Silence after a query. Ninety working days without a response closes a new application automatically.[1] Agree in writing, before filing, who answers technical queries and how fast the factory turns them round.
- Rejected uploads. Non-CTD dossiers, zipped folders, wrong folder names and more than two products per window are all listed grounds for rejection.[4]
- Unauthenticated certificates. A CoPP or GMP certificate without Nigerian-mission authentication does not meet the guideline.[1]
- A short Power of Attorney. It must run at least five years. One that lapses before renewal has to be replaced.[1]
- The wrong product in the first place. Ceiling-list items, prohibited imports, banned formulations, and labels that resemble a registered brand are not accepted.[1]
- Glycol-risk excipients. Syrups and other liquids with glycerin, propylene glycol or sorbitol fall into the high-risk, full-review category.[6]
Most of these are fixed on the manufacturer’s side before the importer files. If you are comparing Indian suppliers, ask each one for its CoPP, GMP certificate and a recent batch CoA for the exact product before you sign. Our note on what a WHO-GMP supplier’s QC evidence should look like lists what to check.
NAFDAC drug registration: questions importers ask
Under NAFDAC’s March 2025 guideline for imported drugs, the official clock is 240 working days from acceptance to registration number, and it stops while NAFDAC waits for the applicant to answer queries. A 2025 study measured a mean of 247 calendar days for generics under full review in 2023. Products eligible for the reliance route have a 60-working-day decision target.
No. The applicant must be a company incorporated with the Corporate Affairs Commission in Nigeria. If the manufacturer owns the brand, the Nigerian applicant files a Power of Attorney from the manufacturer, valid for at least five years. If the Nigerian company owns the brand, it files a Contract Manufacturing Agreement.
NAFDAC’s published tariff, effective January 2020, charges imported products US$967 for an OTC medicine, US$1,280 for a POM 1 and US$1,200 for a POM 2, per product. A GMP inspection of a foreign factory costs US$10,989.01 per site and stays valid for three years. Confirm current figures with NAFDAC before budgeting.
The Certificate of Registration is valid for five years. Renewal is filed on NAPAMS at least six months before expiry. It is processed within 90 working days and costs 80% of the new-registration fee. A renewal query unanswered for 45 working days closes the application.
For a new registration, an applicant who does not respond within 90 working days has the application closed automatically. The registration clock is paused while the query is open, so slow answers lengthen the total time even before closure.
Search NAFDAC’s Greenbook, the public register of approved products, by product name, active ingredient, NAFDAC registration number or applicant. The NAPAMS portal also offers a product verification search by NAFDAC number.
Not yet. Consignments of regulated products from India also need a Clean Report of Inspection and Analysis from a NAFDAC-accredited CRIA agent, a Form M, and inspection at the Nigerian port of entry. Registration is the product-level approval; each shipment is cleared separately.
Keep reading: the Nigeria import lane
Planning a NAFDAC file for an Indian-made product?
Tell us the molecules, strengths and pack sizes you want to register. We will tell you what the manufacturing side can supply for the dossier, the CoPP and GMP authentication, the inspection invitation and the sample CoAs, and where your file is likely to land in NAFDAC’s risk categories.
References
- National Agency for Food and Drug Administration and Control (NAFDAC), Drug Registration and Regulatory Affairs Directorate. Guidelines for registration of imported drug products in Nigeria (human and veterinary drugs). Doc. Ref. DR&R-GDL-005-03. Abuja: NAFDAC; effective 20 Mar 2025. Available from: https://nafdac.gov.ng/regulatory-resources/guidelines/ Accessed 8 Oct 2026.
- NAFDAC. NAFDAC Automated Product Administration and Monitoring System (NAPAMS). Available from: https://registration.nafdac.gov.ng/ Accessed 8 Oct 2026.
- World Health Organization. Ethiopia achieves major milestone in medicines regulation, reaching WHO maturity level 3. Geneva: WHO; 30 Sep 2025. Available from: https://www.who.int/news/item/30-09-2025-ethiopia-achieves-major-milestone-in-medicines-regulation-reaching-who-maturity-level-3 Accessed 8 Oct 2026.
- NAFDAC, DR&R Directorate. Dossier submission guide. Doc. Ref. DR&R-GDN-004-00. Abuja: NAFDAC; effective 19 Jan 2022. Available from: https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Guidelines/DR_And_R_Guidelines/Dossier-Submission-Guide.pdf Accessed 8 Oct 2026.
- NAFDAC. NAFDAC approved tariff. Abuja: NAFDAC; effective 31 Jan 2020. Available from: https://nafdac.gov.ng/regulatory-resources/nafdac-tariff/ Accessed 8 Oct 2026.
- NAFDAC, DR&R Directorate. Guidelines for risk categorization of product dossiers for the registration of drug products for human use. Doc. Ref. DR&R-GDL-033-01. Abuja: NAFDAC; effective 7 Dec 2024. Available from: https://nafdac.gov.ng/regulatory-resources/guidelines/ Accessed 8 Oct 2026.
- NAFDAC, DR&R Directorate. Guidelines for registration and related activities of drugs, vaccines and medical devices including in-vitro diagnostics using the reliance procedure. Doc. Ref. DR&R-GDL-035-01. Abuja: NAFDAC; effective 25 Sep 2025. Available from: https://nafdac.gov.ng/regulatory-resources/guidelines/ Accessed 8 Oct 2026.
- NAFDAC, Registration and Regulatory Affairs Directorate. Guidelines for registration of imported drug products in Nigeria (human and veterinary drugs). Doc. Ref. R&R-GDL-005-00. Abuja: NAFDAC; effective 1 Jun 2018 (superseded). Archived copy available from: https://policyvault.africa/wp-content/uploads/policy/NGA399.pdf Accessed 8 Oct 2026.
- Owusu-Asante M, Darko DM, Seaneke S, Nacoulma A, Traore OIO, Adeyeye MC, et al. Comparison of the review models and regulatory timelines of seven countries participating in the ECOWAS-MRH initiative: identifying opportunities for improvement. Front Med (Lausanne). 2025;12:1587761. doi:10.3389/fmed.2025.1587761. Available from: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1587761/full Accessed 8 Oct 2026.
- NAFDAC. Abridged NAFDAC service charter. Abuja: NAFDAC; undated. Available from: https://www.nafdac.gov.ng/wp-content/uploads/Files/Resources/Regulations/NAFDAC_Acts/ABRIDGED-NAFDAC-SERVICE-CHATER.pdf Accessed 8 Oct 2026.
- NAFDAC. Pre-shipment inspection and testing agents. Abuja: NAFDAC; content current as of 15 Apr 2025. Available from: https://nafdac.gov.ng/regulatory-resources/pre-shipment-inspection-and-testing-agents/ Accessed 8 Oct 2026.
- NAFDAC. NAFDAC Greenbook: Nigeria’s registered product database. Available from: https://greenbook.nafdac.gov.ng/ Accessed 8 Oct 2026.
- NAFDAC, DR&R Directorate. Guidelines for renewal of certificate of registration for drug products (human and veterinary). Doc. Ref. DR&R-GDL-025-04. Abuja: NAFDAC; effective 20 Dec 2024. Available from: https://nafdac.gov.ng/regulatory-resources/guidelines/ Accessed 8 Oct 2026.
This guide is technical and educational information for importers and manufacturers. It is not legal advice, and it does not replace NAFDAC’s own instructions. NAFDAC guidelines, tariffs and portal procedures are revised periodically. Confirm the current requirements with NAFDAC before filing or budgeting. Puizer Cure (OPC) Pvt. Ltd. is a manufacturer and exporter, not a NAFDAC agent.



